2005
DOI: 10.1002/sim.2339
|View full text |Cite
|
Sign up to set email alerts
|

The sequential analysis of repeated binary responses: a score test for the case of three time points

Abstract: In this paper a robust method is developed for the analysis of data consisting of repeated binary observations taken at up to three fixed time points on each subject. The primary objective is to compare outcomes at the last time point, using earlier observations to predict this for subjects with incomplete records. A score test is derived. The method is developed for application to sequential clinical trials, as at interim analyses there will be many incomplete records occurring in non-informative patterns. Mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 23 publications
0
10
0
Order By: Relevance
“…The desire to do this arises when the primary endpoint of interest for each patient is only available after a number of months or even years and yet there are more immediately measured endpoints available, building on earlier work on incorporation of early endpoints in sequential clinical trials comparing a single experimental treatment with a control (Cook and Farewell, 1996;Marschner and Becker, 2001;Galbraith and Marschner, 2003;Sooriyarachchi et al, 2006;Whitehead et al, 2008). An example can be found in secondary progressive multiple sclerosis, where long-term changes in disability scales are the main goal, but early evidence of treatment effect may be observed as changes to lesions in the brain detected using magnetic resonance imaging scanning technology.…”
Section: Introductionmentioning
confidence: 99%
“…The desire to do this arises when the primary endpoint of interest for each patient is only available after a number of months or even years and yet there are more immediately measured endpoints available, building on earlier work on incorporation of early endpoints in sequential clinical trials comparing a single experimental treatment with a control (Cook and Farewell, 1996;Marschner and Becker, 2001;Galbraith and Marschner, 2003;Sooriyarachchi et al, 2006;Whitehead et al, 2008). An example can be found in secondary progressive multiple sclerosis, where long-term changes in disability scales are the main goal, but early evidence of treatment effect may be observed as changes to lesions in the brain detected using magnetic resonance imaging scanning technology.…”
Section: Introductionmentioning
confidence: 99%
“…The test statistics will now be derived using data available from the intermediate assessment for patients who have not yet had their final assessment. Using the notation introduced in [7], the following data structure is assumed. Patients are randomized between an experimental treatment T 1 and a control treatment T 2 serially over time, and at time t 1 after their recruitment their condition is assessed and classified as being in either category C 1 (satisfactory) or category C 2 (unsatisfactory).…”
Section: Inclusion Of Patients With Predicted Second Assessment Outcomesmentioning
confidence: 99%
“…The probability that a patient on treatment T g is in category C i at t 1 and category C j at t 2 will be denoted by p i j,g . The conditional probabilities q (1) i,g = P (category i at t 1 ; T g ) and q (2) i j,g = P(categories i at t 1 and j at t 2 | category i at t 1 ; T g ) can also be defined, and it follows that p i j,g = q (2) i j,g q (1) i,g (7) for i, j, g = 1, 2. Note that the probability that a patient changes category between the two assessments is allowed to differ between the two treatment groups.…”
Section: Inclusion Of Patients With Predicted Second Assessment Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…Several researchers have studied methods that combine data from subjects who have completed full follow-up with those who have been followed for duration R in situations where the outcome is reversible (Marschner and Becker 2001; Sooriyarachchi et al 2006; Whitehead et al 2008). In our research, however, the situation is different in that the outcome can be ascertained at any of the pre-specified visits during follow-up and is irreversible.…”
Section: Introductionmentioning
confidence: 99%